Even though cannabis and its major components, cannabinoids, have been known to benefit the human body and mind for thousands of years, the cannabis industry has just begun experiencing massive growth. This growth is mostly attributed to researchers everywhere who devote their time and knowledge to lift the veil on ambiguities and myths surrounding the plant. These people made decriminalization of cannabis and hemp possible, and CBMs (cannabis-based medicines) are now available in 33 US states.
The Industry Is Increasingly Focusing on CBMs
While there is still a lot of controversy surrounding cannabis, the atmosphere is slowly changing. All the research and the sudden boom of the cannabis industry make lawmakers, doctors, and patients rethink their stances on the plant.
Back in June 2018, the American government approved Epidiolex, and this became the sign of the times (and we mean this in the best way possible). As the FDA recognized the incredible effect of this medicine on conditions like Lennox-Gastaut and Dravet syndromes, there is hope that Epidiolex will be a trailblazer for other cannabis-based drugs in the future.
Cannabis is, unfortunately, still considered a Schedule I drug, making it exceptionally hard to obtain a license to conduct medical research on the plant. However, as the laws get looser, the medicinal cannabis researchers will likely grant us several other medicines that are as successful as Epidiolex in the future.
Another incredible medicine, Sativex, was approved by the FDA back in 2018 and is now helping millions of patients struggling with MS (multiple sclerosis), RA (rheumatoid arthritis), and ALS or amyotrophic lateral sclerosis.
Marinol was approved by the Food and Drug Administration back in 1985 to help patients undergoing chemo with nausea, and those suffering from anorexia in advanced stages of AIDS. The medicine contains synthetic THC, otherwise known as dronabinol. All these medicines imply a bright future of CBMs, as the plant reveals its incredible properties every year.
Other cannabis products, such as oils and tinctures, topicals, and cannabis-infused food and beverages, help people manage stress and anxiety, depression, skin conditions like herpes zoster and acne, etc. The industry is providing some incredible products. If more growers become interested in launching canna-businesses, the competitive market will only bring out the “crème de la crème” of products.
It will be exciting to observe the impact of cannabis on the world of medicine. This rapidly changing industry has a lot to offer, not only in terms of products and medicines, but the economic growth, jobs, and tax revenue as well. If you want to find out more, keep reading. This fun CBD statistics infographic contains more fascinating facts and information.